quire a knowledge of the time-response relations following stimulation with (Einhorn 1958).

Similar documents
might be due to a direct action on the thyroid, like that of the thiouracil

COMPARISONS OF THE DISTRIBUTION OF RADIOACTIVE IODINE IN SERUM AND URINE IN DIFFERENT LEVELS OF THYROID FUNCTION

pg. %o in 13, borderline (3.0 to 3.4 pg. %o) in two,

OGY. IV. THE METABOLISM OF IODINE IN

extensively investigated (see review by Maqsood, 1952), but the possible

Time of maximum uptake of Technetium-99m pertechnetate (TcO4) in the thyroid gland and its correlation with thyroid functional status

thyroid activity to changes in the environmental temperature are in all

EFFECT OF STRESS, TSH AND ACTH ON THE LEVEL OF HORMONAL I 131 OF SERUM REGINALD A. SHIPLEY, M.D. AND FRANK H. MACINTYRE

Estimation of the Secretion Rate of Thyrotropin in Man *

using heifers and young steers, found that testosterone

THYROID STATES IN MAN ", 2

Hugo Studer and Monte A. Greer

(Received 5 November 1956) Work with 131I-labelled thyroxine has shown that the plasma thyroxine is

goiter? The results which have been observed

HIGH INCIDENCE OF BREAST CANCER IN THYROID

Decoding Your Thyroid Tests and Results

Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)

Stanbury, and Brownell have recently demonstrated

Chapter 22 THYROID UPTAKE TEST. R.D. Ganatra

THE use of radioactive iodine as a treatment of choice for the hyperthyroidism

peroxidase activity was observed. It was only at 35 days of iodine deficiency, Partly supported by INSERM ATP

B-Resistance to the action of hormones, Hormone resistance characterized by receptor mediated, postreceptor.

Antithyroid drugs in Graves disease: Are we stretching it too far?

Control of Thyroid Hormone Secretion in Normal Subjects Receiving Iodides

Effectiveness Of Fixed Dose Radioactive Iodine (Rai) For The Treatment Of Thyrotoxicosis : A United Kingdom District General Hospital Experience

THE TEMPORARY NATURE OF THE INHIBITORY ACTION OF EXCESS IODIDE ON ORGANIC IODINE SYNTHESIS IN THE NORMAL THYROID 1

ATROPINE AS AN ANTISIALOGOGUE, COMPARED WITH L-HYOSCYAMINE (BELLAFOLINE), SCOPOLAMINE BUTYLBROMIDE (BUSCOPAN) AND OXYPHENONIUM (ANTRENYL)

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine

FirstDepartment of Internal Medicine, School of Medicine, Gunma University, Maebashi. Endocrinol. Japon. 1960, 7(3),

Alvin C. Powers, M.D. 1/27/06

particularly as a simple and convenient test for the diagnosis of diabetes (for

(Adams 8c Purves 1958), or LATS-protector (LATS-P) (Adams 8c Kennedy. 1967). The failure of the McKenzie (1958) mouse bioassay to detect LATS in

What you need to know about Thyroid Cancer

Amiodarone Induced Thyrotoxicosis Treatment? (AIT)

FELINE THYROID DISEASE: FOCUS ON NEW APPROACHES AND TREATMENTS

Thyrotoxicosis in Pregnancy: Diagnose and Management

Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist

Galactorrhea in Subclinical Hypothyroidism. Division of Endocrinology and Metabolism,

Non Thyroid Surgery. In patients with Thyroid disorders

Thyroid Cancer (Carcinoma)

because it enabled one to determine the reaction of the heart to slight by the use of acetylene (1) in the method previously described (2).

1. Protocol Summary Summary of Trial Design. IoN

Diseases of thyroid & parathyroid glands (1 of 2)

Surgical Treatment of Graves Hyperthyroidism. Bertil Hamberger Karolinska Institutet Stockholm, Sweden

Congenital Hypothyroidism Referral Guidelines for Newborn Bloodspot Screening Wales

SONE ON THE DISTRIBUTION AND PERIPHERAL

Graves Disease in Pediatrics

Observations on the emission of radioactive J-131 during its application on a patient as a treatment against hyperthyroid

Mandana Moosavi 1 and Stuart Kreisman Background

Slide notes: This presentation provides information on Graves disease, a systemic autoimmune disease. Epidemiology, pathology, complications,

Adjuvant therapy for thyroid cancer

Cancer risks in thyroid cancer patients

Thyroid Function. Thyroglobulin Analyte Information

Analysis of Lag Behind Thyrotropin State After Radioiodine Therapy in Hyperthyroid Patients

Nuclear Medicine: Basics to therapy

Feline Hyperthyroid Clinic, frequently asked questions for vets:

PHOSPHORUS METABOLISM OF THE SOFT TISSUES OF THE NORMAL MOUSE AS INDICATED BY RADIOACTIVE PHOSPHORUS '

MEDICAL APPLICATIONS OF RADIO-ACTIVE

Summary of Patient Release after Radioiodine Therapy Research Review

THE VARYING BLOOD LEVELS AFFORDED BY PENICILLINS F, G, K, AND X IN RABBITS AND MAN BY HARRY EAGLE, M.D.

(4). Other workers have reached similar conclusions.

AN INTRODUCTION TO NUCLEAR MEDICINE

THE RENAL HANDLING OF PHOSPHATE IN THYROID DISEASE

Hyperthyroidism Diagnosis and Treatment. April Janet A. Schlechte, M.D.

Name. Endocrinology. d.) What gland in the brain is a major organizing center of hormone release?

Radionuclide & Radiopharmaceuticals

5/3/2017. Ahn et al N Engl J Med 2014; 371

RADIOJODINE THERAPY OF THYROTOXICOSIS. By G. L. JACKSON, M.D.*

CLINICAL PHARMACOLOGY

Thyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA

Fitting a Single-Phase Model to the Post-Exercise Changes in Heart Rate and Oxygen Uptake

Metabolism and Kinetics of Adrenocortical Steroids. -A Consideration on Corticosteroid Therapy-

Thyroid Ectopia in Hyperthyroidism

Take Home Messages in Endocrinology

of the radioimmunoassay for TSH. When thyroid hormone is low, as in myxedema, TSH is elevated, whereas thyroid hormone replacement reduces the

Radionuclide Therapy. Prof. Dr. Çetin Önsel. Cerrahpaşa Medical School Department of Nuclear Medicine. Radionuclide Therapy

Syracwse, N. Y.) occurred. The two determinations were used interchangeably. out of the vascular compartment as it was distributed

Understanding thyroid function tests. Dr. Colette George

Feline iatrogenic hypothyroidism: its recognition and management

I-123 Thyroid Scintigraphy

Cambridge CB2 3EG. ['25I]L-thyroxine. Experiments were performed after 24 hr had elapsed.

HYPERTHYROIDISM. Hypothalamus. Thyrotropin-releasing hormone (TRH) Anterior pituitary gland. Thyroid-stimulating hormone (TSH) Thyroid gland T4, T3

THE THYROID GLAND AND YOUR HEALTH

Treatment of Hyperthyroidism With Iodine-131

Case Report Recurrent Episodes of Thyrotoxicosis in a Man following Pregnancies of his Spouse with Hashimoto s Thyroiditis

AFTER THERAPY. University of New York, Upstate Medical Center, Syracuse, N. Y.) Ingbar and Freinkel (3). The present work was undertaken to observe

Biochemical Studies on the Mineral Components in Sake Yeast. Part V. The Relationship of the Mineral Composition of Yeast to Fermentation

LABORATORY TESTS FOR EVALUATION OF THYROID DISORDERS

Diabetes Centre. Treatment for Overactive Thyroid Gland. Information

Role of Radioactive Iodine-131 in Management of Hyperthyroid Patients Seen at NEMROCK: a Local Experience Study

RADIOIMMUNOASSAY OF THYROID RELATED HORMONES AND TSH IN PRIMARY HYPERTHYROIDISM

International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer

Serum TSH and the response to radioiodine treatment of toxic multinodular goitre

GH Replacement Therapy in Growth Hormone Deficient Adults

THE IODIDE-REPLETION TEST 1

Chapter I.A.1: Thyroid Evaluation Laboratory Testing

Iodide transport in isolated cells of mouse submaxillary gland

Module 2 Endocrine System

Dr J K Jekel Dept. Surgery University of Pretoria

DRAXIMAGE SODIUM IODIDE I 131 CAPSULES, USP DIAGNOSTIC. For Oral Use DESCRIPTION

Transcription:

Radiumhemmet (Professor Sven Hultberg), Karolinska sjukhuset, Stockholm EFFECT OF REPEATED THYROTROPHIN DOSES ON THE UPTAKE OF RADIOACTIVE IODINE BY THE HUMAN THYROID: TIME-RESPONSE RELATIONS By J. Einhorn and Gunnel Wikholm ABSTRACT Three injections of thyrotrophin were administered in euthyroid patients at intervals of 24 hours. Their effects on the iodine accumulation rate in the thyroid were determined at various intervals after the final injection. The iodine accumulation rate increased with repeated TSH injections. The effect reached its maximum 15\p=n-\18hours after the final injection. It is suggested that to ensure the maximal uptake of radioiodine following repeated injections of TSH, the radioiodine dose should be administered approximately 15 hours after the last injection. Thyrotrophin (thyrotrophic hormone, TSH) is used clinically mainly in con nection with investigations and treatment with radioactive iodine. It is useful for tests during the course of thyroid medication and for differential diagnosis between primary hypothyreosis and hypothyreosis due to pituitary insufficiency. It can also be administered during radioiodine therapy of normal, hyperfunctioning, or neoplastic thyroid tissue to increase the uptake of radioiodine by the treated tissue. Both the diagnostic and the therapeutic use of TSH re quire a knowledge of the time-response relations following stimulation with thyrotrophin. These relations have previously been studied in humans after a single dose of thyrotrophic hormone. The iodine accumulation in the thyroid begins to increase after a latent period of 8 hours following the intramuscular injection of thyrotrophin (Stanley 8c Astwood 1949); it reaches a maximum between 18 and 24 hours after the injection and then gradually decreases (Einhorn 1958). Repeated injections of thyrotrophin are often indicated in clinical practice. When this is the case, the iodine-accumulating function of the thyroid is under

the influence of repeated stimuli which have a complex mechanism of action and effects that probably overlap. The present investigation was designed to - elucidate the time-response relations after the last of a series of TSH injections which had been given at intervals of 24 hours. MATERIAL The series consisted of 46 patients with no known thyroid disease, selected from the wards of Radiumhemmet. Patients in poor general condition or with known cardiac or renal disease were excluded, as were those who had received drugs known to influence the thyroid function. METHODS Thyrotrophin (»Actyron«, Ferring, Malmö) was administered by intramuscular in jection. Each patient received a total of three injections of 5 USP units at intervals of 24 hours. The 24-hour interval is, for practical reasons, the one most commonly used in clinical work. The iodine accumulation in the thyroid was determined prior to administration of thyrotrophin and subsequently 18 hours after the first and also after the second injection. In patients determinations were made 12, 15, 18, 24 and 36 hours as well as five days after the third injection. The results reported do not include cases in which any of the projected tests were impracticable. The examinations were made by means of the radioactive isotope 132I (half-life 2.3 hours), which allowed of repeated tests in the same patient at short intervals. A method reported by Larsson 8c Jonsson (1955) was employed for determining the accumulation rate of radioiodine in the thyroid. The tracer dose of 132I was injected intravenously and the counting rates measured over the neck were continuously recorded. The difference between the counting rates 1 minute and 11 minutes after the injection was, after corrections for the physical decay of I32I and for changes in the residual radioactivity in the thyroid during the test period (Einhorn 1958), expressed in per cent of the counting rates ob tained from a solution of 132I with the same activity as that of the administered tracer dose. This value (termed H or initial accumulation rate) is also influenced by changes in extrathyroidal radioiodine within the volume of tissue scanned by the counter; it can be used, however, as an arbitrary index for the accumulation rates of radioiodine in the thyroid (Larsson 1955; Einhorn 1958). The results of the tests in each patient were calculated as the difference between the H value before and after initiation of thyrotrophin treatment (the H difference). A positive difference points to an increase in the iodine accumulation function of the thyroid following administration of thyro trophin. RESULTS There were major individual variations in the magnitude of the effect of thyrotrophin on the accumulation rate, expressed as the H difference. The time curve nevertheless showed a characteristic course which was seen to occur with great regularity in the patients studied. The results are detailed in Fig. 1 and Table 1.

H-diff. percent H-diff per cent 0 12 24 Hours after second q~ TSH injection 12 24 36 V^ Hours after third TSH injection A. The effect on the thyroidal radioiodine accumulation rate reaches its maximum after 15-18 hours, then abates. The tests were made in patients. The broken line re presents the time curve that might be ex pected after the third TSH injection as suming that the effect of repeated injections were purely summative. 120 - Exam, of patients -Exam, of 16 patients TSH ] 5 USP units 12 24 12 24 Hours after third TSH injection B, Effect on the thyroidal radioiodine ac cumulation rate 3-12 hours after the third injection of TSH in a group of 16 patients. Fig. 1. Time-response relations following repeated intramuscular injections of TSH.

Table 1. Time-response relations after the third injection of thyrotrophin (see Fig. 1). The difference calculated between H values at two consecutive tests in the same patient. Differences greater than zero signify an increase, and those smaller than zero a de crease in the thyroidal radioactive iodine accumulation rate during the relevant interval. Time after TSH, hours Number of patients Mean of the differences, per cent Standard error of the mean 12-15 15-18 18-24 24-36 + 1.29 0. 0,84 1.62 0.36 0.34 0.21 0.25 < 0.01 > 0.05 < 0.001 < 0.001 The iodine accumulation rate increased with repeated (three) injections of TSH. No rise or fall of the H value was demonstrable during the 12 hours immediately following the final injection of TSH. Later the H values rose, reaching, in most patients, a maximum 15 or 18 hours after the final injection. Thereafter they tended to return to the original level. Five days after the third injection, however, the values were still significantly higher than they had been prior to administration of TSH (P <C 0.001). For statistical analysis of the results obtained between 12 and 36 hours after the final injection of TSH, individual differences between the H values re corded at two consecutive tests on the same patients, were made up into series, i. e. one for each interval between tests. The mean and standard error were calculated for each series. The t test was used to ascertain whether the means differed significantly from zero (Table 1). Of the intervals studied, that between 12 and 15 hours after the third injection showed a significant increase of the initial accumulation rate. Between 18 and 36 hours there was a continuous fall. The decrease was already significant (P <i 0.001) during the interval from 18 to 24 hours after the final injection. The thyrotrophin dose of 5 USP units daily for three days caused no appre ciable distress in these euthyroid patients. DISCUSSION When three injections of TSH were given at 24-hour intervals, the iodine accumulation rate increased after each dose, though following the final dose, the rise was not demonstrable until 12-15 hours after the injection. Following - a single TSH injection the effect on the iodine accumulating function of the

thyroid can be demonstrated, however, after a latent period of only 8 hours (Stanley 8c Astwood 1949). It reaches its maximum after 18-24 hours and abates rapidly during the second day following the TSH injection (Einhorn 1958). This decrease may overlap any incipient effect of a subsequent injection; hence the apparently longer latent period after the last of the three TSH injections. Similar overlapping may be responsible in part for the fact that the maximum effect after the last series of thyrotrophin injections occurs earlier than that after a single injection. It has been suggested that the optimum time for ad ministering the dose of radioiodine is 18 hours after a single thyrotrophin in jection (Einhorn 8c Larsson 1959). When injections of TSH are repeated at 24-hour intervals, the corresponding optimum time is about 15 hours after the final TSH injection, if the aim is to attain the maximal uptake of radioiodine by the thyroid. In most of the cases reported here, the effect on the thyroidal uptake of radioiodine already decreased during the interval from 18-24 hours after the final dose of TSH. The mechanism of thyrotrophin action on the thyroid gland is not known, but an increased thyroidal uptake of iodine is probably one of the final links in a chain of reactions initiated by the administration of thyrotrophin (Keating et al. 1945; Rawson et al. 1955; cf. Halmi et al. 1953, 1960; Taurog et al. 1958). Overlapping of the effects of repeated thyrotrophin doses would presumably result in initiation of a further chain of reactions before the termination of the preceding one. Since many factors in the thyroid gland are affected by each dose of thyrotrophin, the effect of repeated doses on the thyroidal uptake of radioiodine can scarcely be expected to be merely cumulative. Yet it may be worth while ascertaining whether and in what way the observed time-response relations differ from those which might result from pure summation. Fig. 1 shows the time curve as it might be expected to appear after the third injection of thyrotrophin if the effect of the latter had been added to the effects of the two preceding injections as pure summation. This curve was plotted on the basis of those time-response relations following a single thyrotrophin injection described previously and studied by the same method (Einhorn 1958). The observed time curve does not differ greatly from the summation curve, though the maximum effect on the thyroidal uptake of radioiodine does occur earlier and, moreover, the effect begins to subside earlier than hight have been anticipated. Halmi (1957) and Halmi et al. (1960) observed in a rats a decrease of the thyroid/serum 131I concentration ratio during the first few hours following in jection of TSH. With our technique and TSH doses, however, we have not detected, after the final thyrotrophin injection, any depression of the thyroidal accumulation rate of radioiodine as increased by previous TSH doses (Fig. 1 B). This work was supported by a grant from Swedish Cancer Society.

REFERENCES Baker S. P., Gaffney G. W., Shock N. W. Sc Landowne M.: J. Geront. 14 (1959) 37. Einkorn J.: Studies on the Effect of Thyrotrophic Hormone on the Thyroid Function in Man. Acta radiol. (Stockh.) Suppl. 160 (1958). Einhorn J. Sc Larsson L. G.: J. clin. Endocr. 19 (1959) 28. Halmi N. S., Spirtos.., Bogdanove E. M. Se Lipner H. J.: Endocrinology 52 (1953) 19. Halmi N. S. In: Wolstenholme C. E. W. & Millar E. C. P., Eds. Ciba Found. Colloq. on Endocrinology, vol. 10. Regulation and Mode of Action of Thyroid Hormones. London (1957) 79. Halmi N. S., Granner D. K., Doughman D. J., Peters B. H. Sc Midler G.: Endocrino logy 67 (1960) 70. Keating F. R. Jr., Rawson R. W'., Peacock W. Se Evans R. D.: Endocrinology 36 (1945) 137. Larsson L. G.: Studies on Radioiodine Treatment of Thyrotoxicosis. Acta radiol. (Stockh.) Suppl. 126 (1955). Larsson L. G. Sc Jonsson L.- Acta Radiol. (Stockh.) 43 (1955) 81. Rawson R. W'.. Rail J. E. Sc Sonenberg M. In: Pincus G. & Thimann K. V., Eds. The Hormones, vol. 3. New York (1955) 455. Stanley M. M. Se Astwood..: Endocrinology 44 (1949) 49. Taurog., Tong W. S- Chaikoff I. L.: Endocrinology 62 (1958) 664. Received on January 20th, 1961.